RHS Financial LLC Buys Shares of 1,760 HCA Healthcare, Inc. $HCA

RHS Financial LLC acquired a new stake in HCA Healthcare, Inc. (NYSE:HCA) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 1,760 shares of the company’s stock, valued at approximately $686,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. BlackRock Inc. purchased a new stake in shares of HCA Healthcare during the second quarter worth about $5,069,974,000. Norges Bank acquired a new stake in HCA Healthcare during the fourth quarter worth approximately $1,262,513,000. Life Cycle Investment Partners Ltd acquired a new position in HCA Healthcare in the 4th quarter valued at $374,037,000. Viking Global Investors LP boosted its holdings in shares of HCA Healthcare by 58.5% during the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock worth $717,214,000 after purchasing an additional 690,773 shares during the last quarter. Finally, Northwestern Mutual Wealth Management Co. increased its stake in HCA Healthcare by 4,545.5% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 663,337 shares of the company’s stock valued at $309,686,000 after purchasing an additional 649,058 shares during the last quarter. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

HCA Healthcare Trading Up 1.8%

Shares of HCA stock opened at $412.27 on Wednesday. The company’s fifty day simple moving average is $395.07 and its 200-day simple moving average is $445.35. HCA Healthcare, Inc. has a 52 week low of $353.99 and a 52 week high of $556.52. The company has a market cap of $89.26 billion, a PE ratio of 13.80, a P/E/G ratio of 1.40 and a beta of 1.10.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The firm had revenue of $20.23 billion during the quarter, compared to the consensus estimate of $19.76 billion. During the same period in the prior year, the firm earned $6.84 EPS. The firm’s quarterly revenue was up 8.7% compared to the same quarter last year. Equities research analysts expect that HCA Healthcare, Inc. will post 29.47 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be paid a dividend of $0.78 per share. The ex-dividend date is Wednesday, September 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.8%. HCA Healthcare’s dividend payout ratio (DPR) is currently 10.45%.

Wall Street Analysts Forecast Growth

Several analysts have commented on HCA shares. Oppenheimer lowered their price target on HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating for the company in a report on Monday, July 27th. Truist Financial lowered their target price on shares of HCA Healthcare from $535.00 to $495.00 and set a “buy” rating for the company in a report on Monday, July 27th. Stephens decreased their price target on shares of HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating on the stock in a report on Monday, April 27th. Morgan Stanley cut their target price on HCA Healthcare from $425.00 to $380.00 and set an “underweight” rating on the stock in a research report on Monday, July 27th. Finally, Wells Fargo & Company upped their price target on HCA Healthcare from $369.00 to $381.00 and gave the stock an “equal weight” rating in a research note on Monday, August 3rd. Fourteen equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, HCA Healthcare presently has an average rating of “Moderate Buy” and an average target price of $465.59.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.